Clinical efficacy of lentinan on patients with stomach cancer of lentinan in combination administration with chemotherapeutic agents such as 5FU + mitomycin C or tegafur on patients with advanced or recurrent gastrointestinal cancer has shown that lentinan has been effective in such cases with regard ....
Methods: We analyzed 33 patients who had been histologically diagnosed with adenocarcinoma of the stomach and who had progressed after m-FOLFOX-4 and m-FOLFIRI regimens. Patients were treated with cycles of 75 mg/m2 docetaxel on day 1 every 3 weeks. Results: The median age of the patients ...
The impact of laboratory findings, immune-related adverse events (irAEs), and clinicopathological factors on long-term survival was evaluated using the Cox proportional hazards model. Results The response rate was 11.7% in patients with measurable lesions. The overall and progression-free survival ...
For example, uterine NK cells have very weak activity in killing cancer cells. Recently, studies of large groups of women have failed to find any relationship between the levels of NK cells in the blood and either infertility or miscarriage. These incorrect assumptions have led doctors to ...
“The combination of lanreotide and everolimus significantly prolonged PFS in poor prognostic population of [grade 1 or 2 gastroenteropancreatic neuroendocrine tumors], with a manageable toxicity,” Susumu Hijioka, MD, from the Department of Hepatobiliary and Pancreatic Oncology at the National ...
f, TMBs for somatic mtDNA mutations and mutations to cancer-associated genes are compared between microsatellite stable (MSS) and microsatellite unstable (MSI-High) tumors, for both (n colorectal cancer: MSI=65, MSS=318; n stomach adenocarcinomas: MSI=75, MSS=256). Although MSI-High tumors ...
Metastasis-free survival miRNA: microRNA MRI: Magnetic Resonance Imaging NCI: National Cancer Institute OAR: Organs at Risk OS: Overall Survival PB: Prostate Bed PCa: Prostate Cancer PET-CT: Positron Emission Tomography-Computed Tomography PFS: Progression-free Survival PSA: Prostate ...
Progression-free survival (a) and cancer-specific survival (b) of patients treated with preoperative IM therapy, followed by surgery and postoperative IM therapy Full size image Discussion GIST is the most common mesenchymal tumor occurring in the digestive tract and originates from mesenchymal stem ...
Despite optimal treatment of advanced epithelial ovarian cancer (EOC), the recurrence rate remains high at more than 70 % [1, 2]. The role of iterative or secondary cytoreductive surgery (sCRS) remains a topic of debate, with one trial showing no survival benefit, another showing a benefit...
In 54 patients with advanced gastric, gastro-oesophageal junction, or oesophageal adenocarcinomas with CLDN18.2 expression in ≥50% of tumour cells, zolbetuximab was well tolerated and exhibited antitumour activity with a clinical benefit rate of 23%. Introduction Gastric cancer (GC) is one of ...